CRISPR Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 3,416 | 0.00402% |
Individual Insiders | 485,977 | 0.573% |
General Public | 30,417,229 | 35.8% |
Institutions | 53,976,469 | 63.6% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 7.6%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
8,157,028 | R$2.2b | -4.44% | 3.39% | |||
6,420,736 | R$1.8b | 0.92% | 0.02% | |||
4,475,532 | R$1.2b | -1.02% | 0.02% | |||
3,268,785 | R$899.0m | -3% | 0.07% | |||
2,516,486 | R$692.1m | -7.25% | no data | |||
1,839,029 | R$505.8m | -10.6% | 0.01% | |||
1,753,497 | R$482.2m | -6.97% | no data | |||
1,590,651 | R$437.4m | 3.37% | no data | |||
1,587,854 | R$436.7m | 0% | 4.59% | |||
1,067,351 | R$293.5m | -2.65% | 0.08% | |||
1,048,951 | R$288.5m | 0% | 16.73% | |||
900,400 | R$247.6m | 0.22% | 0.55% | |||
883,729 | R$243.0m | 3.98% | no data | |||
779,454 | R$214.4m | -11.4% | 0.01% | |||
726,887 | R$199.9m | 0% | 0.15% | |||
699,332 | R$192.3m | -5.79% | 0.03% | |||
653,023 | R$179.6m | 0% | 0.01% | |||
617,586 | R$169.8m | -13.7% | no data | |||
549,007 | R$151.0m | 19.7% | 0.01% | |||
508,100 | R$139.7m | 0% | 0.07% | |||
498,558 | R$137.1m | 0% | 8.38% | |||
475,008 | R$130.6m | 280% | 0.03% | |||
422,763 | R$116.3m | -4.15% | 0.01% | |||
408,122 | R$112.2m | 5.36% | no data | |||
406,855 | R$111.9m | -5.44% | no data |